152 related articles for article (PubMed ID: 32519016)
1. Ovarian Sertoli-Leydig and granulosa cell tumor: comparison of epidemiology and survival outcomes.
Nasioudis D; Mastroyannis SA; F Haggerty A; M Ko E; Latif NA
Arch Gynecol Obstet; 2020 Aug; 302(2):481-486. PubMed ID: 32519016
[TBL] [Abstract][Full Text] [Related]
2. Contribution of lymph node staging method and prognostic factors in malignant ovarian sex cord-stromal tumors: A world wide database analysis.
Wang J; Li J; Chen R; Lu X
Eur J Surg Oncol; 2018 Jul; 44(7):1054-1061. PubMed ID: 29705285
[TBL] [Abstract][Full Text] [Related]
3. DICER1 and FOXL2 mutations in ovarian sex cord-stromal tumours: a GINECO Group study.
Goulvent T; Ray-Coquard I; Borel S; Haddad V; Devouassoux-Shisheboran M; Vacher-Lavenu MC; Pujade-Laurraine E; Savina A; Maillet D; Gillet G; Treilleux I; Rimokh R
Histopathology; 2016 Jan; 68(2):279-85. PubMed ID: 26033501
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the Prognostic Outcome between High-Grade Ovarian Sertoli-Leydig Cell Tumors (SLCTs) and Low-Grade SLCTs.
Eoh KJ; Park J; Kim HM; Lee M; Kim YT
Yonsei Med J; 2021 Apr; 62(4):366-369. PubMed ID: 33779091
[TBL] [Abstract][Full Text] [Related]
5. Unclassified ovarian gonadal stromal tumors. A clinicopathologic study of 32 cases.
Seidman JD
Am J Surg Pathol; 1996 Jun; 20(6):699-706. PubMed ID: 8651349
[TBL] [Abstract][Full Text] [Related]
6. Ovarian Sertoli-Leydig Cell Tumors: Epidemiological, Clinical and Prognostic Factors.
Castro BGR; Souza CP; Andrade CEMDC; Vieira MA; Andrade DAP; Reis RD
Rev Bras Ginecol Obstet; 2019 Jul; 41(7):440-448. PubMed ID: 31344718
[TBL] [Abstract][Full Text] [Related]
7. Role of adjuvant chemotherapy in the management of non-granulosa cell ovarian sex cord-stromal tumors.
Nasioudis D; Orfanelli T; Frey MK; Chapman-Davis E; Caputo TA; Witkin SS; Holcomb K
J Gynecol Oncol; 2019 Mar; 30(2):e19. PubMed ID: 30740951
[TBL] [Abstract][Full Text] [Related]
8. Results from a Monocentric Long-Term Analysis of 23 Patients with Ovarian Sertoli-Leydig Cell Tumors.
Gouy S; Arfi A; Maulard A; Pautier P; Bentivegna E; Leary A; Chargari C; Genestie C; Morice P
Oncologist; 2019 May; 24(5):702-709. PubMed ID: 30201740
[TBL] [Abstract][Full Text] [Related]
9. DICER1-related Sertoli-Leydig cell tumor and gynandroblastoma: Clinical and genetic findings from the International Ovarian and Testicular Stromal Tumor Registry.
Schultz KAP; Harris AK; Finch M; Dehner LP; Brown JB; Gershenson DM; Young RH; Field A; Yu W; Turner J; Cost NG; Schneider DT; Stewart DR; Frazier AL; Messinger Y; Hill DA
Gynecol Oncol; 2017 Dec; 147(3):521-527. PubMed ID: 29037807
[TBL] [Abstract][Full Text] [Related]
10. Sex cord stromal tumours of the ovary, experience at Shifa International Hospital Islamabad.
Qureshi A; Hassan M; Mamoon N; Ali Z; Ahmed IN
J Pak Med Assoc; 2017 Jul; 67(7):1107-1108. PubMed ID: 28770898
[TBL] [Abstract][Full Text] [Related]
11. [Thecoma, granulosa cell carcinoma and arrhenoblastoma of the ovaries].
Lukić D; Vukajlović J; Dordević V
Srp Arh Celok Lek; 1967 Dec; 95(12):1153-62. PubMed ID: 4303042
[No Abstract] [Full Text] [Related]
12. Imaging in gynecological disease (27): clinical and ultrasound characteristics of recurrent ovarian stromal cell tumors.
Moro F; Giudice MT; Bolomini G; Moruzzi MC; Mascilini F; Quagliozzi L; Ciccarone F; Scambia G; Fagotti A; Valentin L; Testa AC
Ultrasound Obstet Gynecol; 2024 Mar; 63(3):399-407. PubMed ID: 37774092
[TBL] [Abstract][Full Text] [Related]
13. Treatment of poor-prognosis sex cord-stromal tumors of the ovary with the combination of bleomycin, etoposide, and cisplatin.
Gershenson DM; Morris M; Burke TW; Levenback C; Matthews CM; Wharton JT
Obstet Gynecol; 1996 Apr; 87(4):527-31. PubMed ID: 8602303
[TBL] [Abstract][Full Text] [Related]
14. DICER1 hotspot mutations in ovarian Sertoli-Leydig cell tumors: a potential association with androgenic effects.
Kato N; Kusumi T; Kamataki A; Tsunoda R; Fukase M; Kurose A
Hum Pathol; 2017 Jan; 59():41-47. PubMed ID: 27664536
[TBL] [Abstract][Full Text] [Related]
15. 14-3-3 sigma is a useful immunohistochemical marker for diagnosing ovarian granulosa cell tumors and steroid cell tumors.
Chen L; Yang B
Int J Gynecol Pathol; 2013 Mar; 32(2):156-62. PubMed ID: 23370648
[TBL] [Abstract][Full Text] [Related]
16. Sertoli-Leydig cell tumor of ovary in children: A report of two cases, including retiform variant.
Sarkar P; Sengupta M; Chatterjee U; Ghosh D
Indian J Pathol Microbiol; 2021; 64(3):559-562. PubMed ID: 34341273
[TBL] [Abstract][Full Text] [Related]
17. Estrogen receptor alpha and progesterone receptor expression in ovarian adult granulosa cell tumors and Sertoli-Leydig cell tumors.
Farinola MA; Gown AM; Judson K; Ronnett BM; Barry TS; Movahedi-Lankarani S; Vang R
Int J Gynecol Pathol; 2007 Oct; 26(4):375-82. PubMed ID: 17885486
[TBL] [Abstract][Full Text] [Related]
18. Use of monoclonal antibody against human inhibin as a marker for sex cord-stromal tumors of the ovary.
Rishi M; Howard LN; Bratthauer GL; Tavassoli FA
Am J Surg Pathol; 1997 May; 21(5):583-9. PubMed ID: 9158684
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of Patients With Sertoli and Leydig Cell Testis Neoplasms From a National Population-Based Registry.
Osbun N; Winters B; Holt SK; Schade GR; Lin DW; Wright JL
Clin Genitourin Cancer; 2017 Apr; 15(2):e263-e266. PubMed ID: 27594555
[TBL] [Abstract][Full Text] [Related]
20. [Sex cord-stromal tumors of the ovary : Current aspects with a focus on granulosa cell tumors, Sertoli-Leydig cell tumors, and gynandroblastomas].
Kommoss F; Lehr HA
Pathologe; 2019 Feb; 40(1):61-72. PubMed ID: 30659330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
